Polianta Ltd’s Moderna MRNA Stock Holding History

Polianta Ltd’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-12,500	Closed	-$835K	–	84
2024 Q3	$835K	Buy	+12,500	New	+$1.15M	0.39%	70
2023 Q3	–	Sell	-8,800	Closed	-$1.07M	–	88
2023 Q2	$1.07M	Buy	+8,800	New	+$1.17M	0.5%	46
2022 Q2	–	Sell	-5,100	Closed	-$878K	–	87
2022 Q1	$878K	Buy	+5,100	New	+$859K	0.57%	61
2021 Q4	–	Sell	-3,000	Closed	-$1.15M	–	88
2021 Q3	$1.15M	Buy	+3,000	New	+$1.11M	0.54%	58
2021 Q2	–	Sell	-8,900	Closed	-$1.17M	–	91
2021 Q1	$1.17M	Buy	+8,900	New	+$1.29M	0.65%	35

Other funds holding MRNA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Polianta Ltd's MRNA Position: Q4 2024 in Review

Polianta Ltd sold out of Moderna (MRNA) in Q4 2024, closing a stake of 12,500 shares — an estimated $835K sold.

Polianta Ltd first reported a position in MRNA in Q1 2021 and held it in 5 quarters. The position peaked at $1.17M in Q1 2021. 745 funds tracked by Wall St. Rank hold MRNA as of Q4 2024.

Polianta Ltd reported no remaining Moderna position as of Q4 2024 after selling out during the quarter.
Polianta Ltd sold 12,500 Moderna shares in Q4 2024, an estimated $835K.
Polianta Ltd first reported a position in Moderna in Q1 2021 and held it in 5 quarters.
Polianta Ltd's Moderna position peaked at $1.17M in Q1 2021.
745 funds tracked by Wall St. Rank held Moderna as of Q4 2024.

Based on Polianta Ltd's 13F filing for Q4 2024, filed 16 Jan 2025.